NR1H4 and hepatocellular carcinoma: This discovery represented the first elucidation of the underlying mechanism by which FXR regulated CSCs, thereby expanding our understanding of its role in tumor inhibition and providing a theoretical basis for clinical treatment of HCC, as well as the development of drugs targeting CSCs.